Sana Biotechnology, Inc. (SANA)
NASDAQ • Healthcare
Last close at September 9, 2026 at 20:00 UTC
Metrics Over Time
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Nov 5
in 56 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
About Sana Biotechnology, Inc.
Sana Biotechnology, Inc. (NASDAQ: SANA) is a small-cap biotechnology company developing treatments built from engineered cells. Founded in 2018, Sana works through advanced ex vivo and in vivo cell engineering platforms, using engineered cells to create therapies, and it has traded publicly since its 2021 NASDAQ listing.
Today's Snapshot
SANA ended yesterday 8.1% down at 3.17.
Trading Volume
Above 10d avg 3.0M
8.6M
vs S&P 500 Today
Strong Underperformance
-7.64%
Updated: September 10, 2026 at 12:07 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$3.54 - $3.75Sell
- RSI (14)36.23Neutral
- Stochastic %K (14, 3, 3)16.99Buy
- MACD Level (12, 26)0.01Neutral
Peers & Related Assets
Get premium market insights delivered directly to your inbox.